Egresi Anna, Lengyel Gabriella, Somogyi Anikó, Blázovics Anna, Hagymási Krisztina
II. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Szentkirályi u. 46., 1088.
Farmakognóziai Intézet, Semmelweis Egyetem, Gyógyszerésztudományi Kar Budapest.
Orv Hetil. 2016 Feb 21;157(8):290-7. doi: 10.1556/650.2015.30377.
As the result of various effects (viruses, metabolic diseases, nutritional factors, toxic agents, autoimmune processes) abnormal liver function, liver steatosis and connective tissue remodeling may develop. Progression of this process is complex including various pathways and a number of factors. The authors summarize the factors involved in the progression of chronic liver disease. They describe the role of cells and the produced inflammatory mediators and cytokines, as well as the relationship between the disease and the intestinal flora. They emphasize the role of oxidative stress, mitochondrial dysfunction and cell death in disease progression. Insulin resistance and micro-elements (iron, copper) in relation to liver damage are also discussed, and genetic and epigenetic aspects underlying disease progression are summarized. Discovery of novel treatment options, assessment of the effectiveness of treatment, as well as the success and proper timing of liver transplantation may depend on a better understanding of the process of disease progression.
由于多种因素(病毒、代谢性疾病、营养因素、有毒物质、自身免疫过程)的影响,可能会出现肝功能异常、肝脂肪变性和结缔组织重塑。这个过程的进展很复杂,涉及多种途径和许多因素。作者总结了慢性肝病进展过程中涉及的因素。他们描述了细胞以及所产生的炎症介质和细胞因子的作用,以及疾病与肠道菌群之间的关系。他们强调氧化应激、线粒体功能障碍和细胞死亡在疾病进展中的作用。还讨论了胰岛素抵抗和微量元素(铁、铜)与肝损伤的关系,并总结了疾病进展背后的遗传和表观遗传方面。发现新的治疗方案、评估治疗效果以及肝移植的成功与否和合适时机可能取决于对疾病进展过程的更好理解。